Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danner

Showing results (1011-1020 of 1,521) with videos related to

Pageof 153
Sort By:
Journal of the Royal Society, Interface|December 4, 2015
The microscopic network structure of mussel (Mytilus) adhesive plaquesEmmanouela Filippidi, Daniel G DeMartini, Paula Malo de Molina, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|June 1, 1996
Controlled trials of rG-CSF and CD11b-directed MAb during hyperoxia and E. coli pneumonia in ratsB D Freeman, R Correa, W Karzai, et al.
Journal of Leukocyte Biology|May 10, 2008
Immune responses to Pneumocystis murina are robust in healthy mice but largely absent in CD40 ligand-deficient miceBeatriz Hernandez-Novoa, Lisa Bishop, Carolea Logun, et al.
Frontiers in Oncology|February 2, 2026
Persistent bothersome urinary frequency following stereotactic body radiation therapy for clinically localized prostate cancer: rationale for prophylactic β3-agonist in men with elevated baseline international prostate symptom scoresJennifer Zack, Min Ji Koh, Emily Lindbloom, et al.
Pharmacotherapy|February 13, 2013
Pharmacokinetics of intravenous voriconazole in obese patients: implications of CYP2C19 homozygous poor metabolizer genotypeBrad Moriyama, Paul F Jarosinski, William D Figg, et al.
The New England Journal of Medicine|December 7, 1995
A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study GroupS A Danner, A Carr, J M Leonard, et al.
The Journal of Infectious Diseases|June 1, 1995
Rapid changes in human immunodeficiency virus type 1 RNA load and appearance of drug-resistant virus populations in persons treated with lamivudine (3TC)R Schuurman, M Nijhuis, R van Leeuwen, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|January 7, 1998
rG-CSF reduces endotoxemia and improves survival during E. coli pneumoniaB D Freeman, Z Quezado, F Zeni, et al.
Chest|July 26, 2016
Estimating Ten-Year Trends in Septic Shock Incidence and Mortality in United States Academic Medical Centers Using Clinical DataSameer S Kadri, Chanu Rhee, Jeffrey R Strich, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 12, 2018
Stability of isoniazid injection in i.v. solutionsJun H Lee, Brad Moriyama, Stacey A Henning, et al.
Pageof 153

Showing results (1011-1020 of 1,521) with videos related to

Sort By:
Pageof 153
Journal of the Royal Society, Interface|December 4, 2015
The microscopic network structure of mussel (Mytilus) adhesive plaquesEmmanouela Filippidi, Daniel G DeMartini, Paula Malo de Molina, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|June 1, 1996
Controlled trials of rG-CSF and CD11b-directed MAb during hyperoxia and E. coli pneumonia in ratsB D Freeman, R Correa, W Karzai, et al.
Journal of Leukocyte Biology|May 10, 2008
Immune responses to Pneumocystis murina are robust in healthy mice but largely absent in CD40 ligand-deficient miceBeatriz Hernandez-Novoa, Lisa Bishop, Carolea Logun, et al.
Frontiers in Oncology|February 2, 2026
Persistent bothersome urinary frequency following stereotactic body radiation therapy for clinically localized prostate cancer: rationale for prophylactic β3-agonist in men with elevated baseline international prostate symptom scoresJennifer Zack, Min Ji Koh, Emily Lindbloom, et al.
Pharmacotherapy|February 13, 2013
Pharmacokinetics of intravenous voriconazole in obese patients: implications of CYP2C19 homozygous poor metabolizer genotypeBrad Moriyama, Paul F Jarosinski, William D Figg, et al.
The New England Journal of Medicine|December 7, 1995
A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study GroupS A Danner, A Carr, J M Leonard, et al.
The Journal of Infectious Diseases|June 1, 1995
Rapid changes in human immunodeficiency virus type 1 RNA load and appearance of drug-resistant virus populations in persons treated with lamivudine (3TC)R Schuurman, M Nijhuis, R van Leeuwen, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|January 7, 1998
rG-CSF reduces endotoxemia and improves survival during E. coli pneumoniaB D Freeman, Z Quezado, F Zeni, et al.
Chest|July 26, 2016
Estimating Ten-Year Trends in Septic Shock Incidence and Mortality in United States Academic Medical Centers Using Clinical DataSameer S Kadri, Chanu Rhee, Jeffrey R Strich, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 12, 2018
Stability of isoniazid injection in i.v. solutionsJun H Lee, Brad Moriyama, Stacey A Henning, et al.
Pageof 153